Clinical Trials Logo

Unipolar Major Depression clinical trials

View clinical trials related to Unipolar Major Depression.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02637466 Withdrawn - Clinical trials for Unipolar Major Depression

Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

Start date: July 2016
Phase: Phase 4
Study type: Interventional

The purpose of this antidepressant study is to determine the efficacy of vortioxetine on depression and cognition in 80 women with breast cancer, and to elucidate inflammatory-mediated mechanisms by which depression and its treatment influence cancer outcome. Our hypothesis is that effective vortioxetine antidepressant therapy in depressed women with breast cancer will attenuate increased intermediate endpoints of inflammation that contribute to the pathogenesis of depression, cognitive impairment, and cancer progression